National Health Investors, Inc.

General ticker "NHI" information:

  • Sector: Real Estate
  • Industry: Health Care REITs
  • Capitalization: $3.2B (TTM average)

National Health Investors, Inc. follows the US Stock Market performance with the rate: 24.3%.

Estimated limits based on current volatility of 0.9%: low 74.39$, high 75.81$

Factors to consider:

  • Earnings expected soon, date: 2025-05-05 amc
  • Company pays dividends (quarterly): last record date 2025-03-31, amount 0.90$ (Y4.74%)
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [53.76$, 76.12$]
  • 2025-12-31 to 2026-12-31 estimated range: [47.12$, 68.93$]

Financial Metrics affecting the NHI estimates:

  • Positive: Non-GAAP EPS, $ of 4.44 > 2.19
  • Positive: 2.69 < Return on assets ratio (scaled to [-100,100]) of 5.01
  • Positive: 1.79 < Operating cash flow per share per price, % of 6.48
  • Positive: Operating profit margin, % of 83.56 > 18.46
  • Positive: 43.26 < Shareholder equity ratio, % of 52.27 <= 63.75
  • Negative: Interest expense per share, $ of 1.28 > 0.67
  • Positive: Industry earnings per price (median), % of 6.55 > 5.55

Similar symbols

Short-term NHI quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-02666870727476
Price $

Long-term NHI plot with estimates

40455055606570758085Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.51
NHIS&P500Real EstateNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $278.19MM $319.83MM $257.05MM
Operating Expenses $197.08MM $141.04MM $42.25MM
Operating Income $81.11MM $178.79MM $214.80MM
Non-Operating Income $-15.61MM $-44.41MM $-78.20MM
Interest Expense $44.92MM $55.51MM $56.12MM
R&D Expense $0.00MM $0.00MM $0.00MM
Income(Loss) $65.50MM $134.38MM $136.59MM
Taxes $42.44MM $0.00MM $-1.27MM
Profit(Loss)* $23.96MM $135.65MM $139.21MM
Stockholders Equity $1,270.22MM $1,253.95MM $1,366.47MM
Assets $2,507.42MM $2,488.48MM $2,614.37MM
Operating Cash Flow $185.34MM $184.45MM $207.77MM
Capital expenditure $4.63MM $3.74MM $0.00MM
Investing Cash Flow $197.94MM $-11.63MM $-192.31MM
Financing Cash Flow $-401.25MM $-169.72MM $-13.57MM
Earnings Per Share** $0.54 $3.13 $3.18

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.